Back to top
more

Galmed Pharmaceuticals (GLMD)

(Delayed Data from NSDQ)

$3.10 USD

3.10
102,035

-0.27 (-8.01%)

Updated Nov 6, 2024 04:00 PM ET

Pre-Market: $3.25 +0.15 (4.84%) 9:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 251)

Industry: Medical - Drugs

Zacks News

Intercept (ICPT) Gains on Earnings and Revenue Beat in Q3

Intercept's (ICPT) revenues beat estimates, owing to strong Ocaliva sales in the third quarter of 2018.

    Intercept (ICPT) Gains on Solid Q2 Results, Ocaliva Recovers

    Intercept (ICPT) gains on a better-than-expected second quarter as loss narrows and sales surpass estimates on a significant recovery in Ocaliva.

      Galmed Pharmaceuticals (GLMD) Reports Q2 Loss

      Galmed Pharmaceuticals (GLMD) delivered earnings and revenue surprises of -6.25% and 0.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

        Medical-Drugs Stock Outlook: No Respite from Near-Term Pain

        Small drugmakers, in general, are having a rather poor year, the principle reason being failure of key pipeline candidates in pivotal studies.

          What's in Store for Universal Health's (UHS) Q2 Earnings?

          Universal Health's (UHS) Q2 is likely to benefit from strong performances at its Acute Care and Behavioral Health segments.

            What's in the Cards for HCA Healthcare (HCA) in Q2 Earnings?

            HCA Healthcare's (HCA) Q2 results are likely to be aided by a strong top line, riding on higher admissions, partially offset by increasing costs.

              Galmed (GLMD) Soars on Positive NASH Data on Aramchol

              Shares of Galmed Pharmaceuticals (GLMD) surges significantly following positive top-line results on lead candidate Aramchol in NASH patients.

                3 Reasons Why Galmed Pharmaceuticals (GLMD) is a Great Momentum Stock

                Momentum stock investors will love Galmed Pharmaceuticals (GLMD) as it has favorable price performance and is also seeing positive estimate revisions.

                  Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%

                  Galmed Pharmaceuticals Ltd. (GLMD) shares jumped nearly 16% in the last trading session.